Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
C-MER Eye Care Holdings Limited ( (HK:3309) ) just unveiled an update.
C-MER Medical Holdings Limited reported its interim results for the first half of 2025, showing a 2.4% increase in revenue and a 15.5% rise in profit compared to the same period in 2024. The company’s adjusted profit attributable to equity holders saw a significant increase of 74.5%, indicating strong financial performance and operational efficiency. This growth reflects positively on the company’s market positioning and could have favorable implications for stakeholders.
The most recent analyst rating on (HK:3309) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on C-MER Eye Care Holdings Limited stock, see the HK:3309 Stock Forecast page.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the medical industry. The company focuses on eye care services and holds a significant market position in Hong Kong and Mainland China.
Average Trading Volume: 988,350
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.55B
See more data about 3309 stock on TipRanks’ Stock Analysis page.